Evolution of interventional cardiology in France during the last decade (1991 -2000);Évolution de la cardiologie interventionnelle en France au cours de la dernière décennie (1991-2000)

Archives des Maladies du Coeur et des Vaisseaux

Volumn 95, Issue 12, 2002, Pages 1188-1194

  Le Tourneau, T ^a   Blanchard, D ^a   Lablanche, J M ^a   Monassier, J P ^a   Morice, M C ^a   Cribier, A ^a   Meier, P ^a   Puel, J ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; TICLOPIDINE;

ANGIOCARDIOGRAPHY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; CORONARY STENT; ENDOPROSTHESIS; FRANCE; HEART MUSCLE REVASCULARIZATION; HUMAN; IMPLANTATION; INTERVENTIONAL RADIOLOGY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; REVIEW; THROMBOEMBOLISM; TRANSLUMINAL CORONARY ANGIOPLASTY; ANGIOPLASTY; ARTICLE; CARDIOLOGY; CORONARY ARTERY OBSTRUCTION; HEART VALVE REPLACEMENT; RETROSPECTIVE STUDY; STATISTICS; STENT;

ANGIOPLASTY; CARDIOLOGY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FRANCE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; RETROSPECTIVE STUDIES; STENTS;

EID: 0036883255     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Sigwart U, Puel J, Mirkovitch V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal an angioplasty. N Engl J Med 1987; 316: 701-6.
2. Rowe MH, Hinohara T, White NW, Robertson GC, Selmon MR, Simpson JB. Comparison of dissection rates and angiographic results following directional coronary atherectomy and coronary angioplasty. Am J Cordial 1990; 66: 49-53.
3. Fourrier JL, Bertrand ME, Auth DC, Lablanche JM, Gommeaux A, Brunetaud JM. Percutaneous coronary rotational angioplasty in humans: preliminary report. J Am Coll Cordial 1989; 14: 1278-82.
4. Serruys PW, de Jaegere P, Kiemeneij F et al., for the Benestent Study Group. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994; 331: 489-95.
5. Fischman DL, Leon MB, Baim DS et al., for the Stent Restenasis Study Investigators. A randomized comparison of coronarystent placement and balloon angioplasty in the treatment af coronary artery disease. N Engl J Med 1994; 331: 496-501.
6. Barragan P, Sainsous J, Silvestri M et al. Ticlopidine and subcutaneous heparin as an alternative regimen following coronary stenting. Cathet Cardiavasc Diagn 1994; 32: 133-8.
7. Karillan GJ, Morice MC, Benveniste E et al. Intracoranary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy. 30-day outcome of the french multicenter registry. Circulation 1996; 94: 1519-27.
8. Lablanche JM, McFadden EP, Bonnet JL et al. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoranary stent management. Eur Heart J 1996; 17: 1373-80.
9. Mehta SR, Yusuf S, Peters RJG et al., far the Clopidogrel in Unstable angina to prevent Recurrent Events trial (Cure) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001; 358: 527-33.
10. Use of o monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC investigation. N Engl J Med 1994; 330: 956-61.
11. Novel dosing regimen of eptifibotide in planned coronary stent implantation (ESPRIT): a randomised, placebo-controlled trial. Lancet 2000; 356: 2037-44.
12. Mintz GS, Popma JJ, Pichard AD et al. Arterial remodeling after coronary angioplasty. A serial intravascular ultrasound study. Circulation 1996; 94: 35-43.
13. Loblanche JM, Van Belle E, McFadden E et al. Angioscopie coronaire. Arch Mal Cœur 1997; 90 (II): 29-33.
14. Sousa JE, Costa MA, Abizaid AC et al. Sustained suppression of neaintimal proliferation by sirolimus-eluting stents: one year angiographic and intravascular ultrasound follow-up. Circulation 2001; 104: 2007-11.
15. Morice MC, Serruys PW, Sousa JE et al. A randomized comparison of a sirolimus-eluting stent with ci standard stent for coronary revascularization. N Engl J Med 2002; 346: 1773-80.
16. Blanchard D, Lablanche JM. Rapport sur la cardiologie interventionnelle coranaire en France. Arch Mal Cœur 2000; 93: 159-66.
17. Sheldon WC. Trends in Cardiac Catheterization Laborataries in the United States. Cathet Cardiavasc Intervent 2001; 53: 40-5.
18. Adamian M, Colombo A, Briguori C et al. Cutting balloon angioplasty for the treatment at in-stent restenosis: a matched comparison with rotational atherectomy, additional stent implantation and balloon angioplasty. J Am Coll Cardial 2001; 38: 672-9.
19. Meyer P, Barragan P, Blanchard D et al. Recommendations de la Société française de cardialagie concernant la formation des médecins caronarographistes et angioplasticiens, l'organisation et l'équipement des centres de coronaragraphie et d'angioplastie coranaire. Arch Mal Cœur 2000; 93: 147-58.
20. Maier W, Windecker S, Lablanche JM, Mühlberger V, Wijns W, Meier B on behalf of the working group Coronary Circulation of the European Society af Cardiology. Eur Heart J 2001; 22: 373-7.
21. Hirshfeld JW, Ellis SG, Faxon DP. Recommendations for the assessment and maintenance af proficiency in coronary interventional procedures. J Am Coll Cardiol 1998; 31: 722-43.
22. Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King III SB. Relation of operator volume and experience to procedural outcome of percutaneous coronary revoscularization at hospitals with high interventional volumes. Circulation 1997; 95: 2479-84.
23. Malenka DJ, McGrath PD, Wennberg DE et al. The relationship between operator volume and outcome after percutaneous coronary interventions in high volume hospitals in 1994-1996. The Northern New England experience. J Am Coll Cardiol 1999; 34: 1471-80.